Piero Anversa

Active 1971–2014

166
Papers
54,433
Citations
114
h-index
166
i10-index

Citations

Citations per year for Piero Anversa1973: 2 citations1975: 1 citations1976: 1 citations1977: 2 citations1978: 1 citations1979: 3 citations1980: 22 citations1981: 15 citations1982: 7 citations1983: 18 citations1984: 11 citations1985: 16 citations1986: 17 citations1987: 9 citations1988: 31 citations1989: 17 citations1990: 49 citations1991: 39 citations1992: 66 citations1993: 35 citations1994: 58 citations1995: 92 citations1996: 83 citations1997: 186 citations1998: 302 citations1999: 312 citations2000: 377 citations2001: 357 citations2002: 596 citations2003: 710 citations2004: 743 citations2005: 733 citations2006: 825 citations2007: 746 citations2008: 727 citations2009: 557 citations2010: 716 citations2011: 683 citations2012: 675 citations2013: 548 citations2014: 529 citations2015: 405 citations2016: 344 citations2017: 287 citations2018: 287 citations2019: 583 citations2020: 539 citations2021: 472 citations2022: 276 citations2023: 200 citations2024: 256 citations2025: 112 citations2026: 4 citations1974: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 4,004 citing papers, 35.7% of this breakdownChina: 841 citing papers, 7.5% of this breakdownItaly: 735 citing papers, 6.6% of this breakdownGermany: 721 citing papers, 6.4% of this breakdownUnited Kingdom: 667 citing papers, 5.9% of this breakdownJapan: 505 citing papers, 4.5% of this breakdownCanada: 391 citing papers, 3.5% of this breakdownNetherlands: 269 citing papers, 2.4% of this breakdownFrance: 256 citing papers, 2.3% of this breakdownAustralia: 248 citing papers, 2.2% of this breakdownSpain: 210 citing papers, 1.9% of this breakdownSouth Korea: 157 citing papers, 1.4% of this breakdown
0%35.7%Other 19.7%

Fields

  • Medicine63.7%
  • Biochemistry, Genetics and Molecular Biology29.1%
  • Materials Science1.8%
  • Neuroscience1.6%
  • Engineering1.5%
  • Immunology and Microbiology1%
  • Other1.3%

Topics

  • Tissue Engineering and Regenerative Medicine6.9%
  • Mesenchymal stem cell research6.2%
  • Cardiac Fibrosis and Remodeling4.7%
  • Congenital heart defects research3.6%
  • Cardiovascular Function and Risk Factors3.6%
  • Electrospun Nanofibers in Biomedical Applications2.8%
  • Other72.2%

Coauthors

All papers

Open in search
  1. Bone marrow cells regenerate infarcted myocardium

    Authors: , , , , , , , , , , , - Nature 2001 cited by 5,177

  2. Adult Cardiac Stem Cells Are Multipotent and Support Myocardial Regeneration

    Authors: , , , , , , , , , , , , , - Cell 2003 cited by 3,542

  3. Cardiomyopathy of the aging human heart. Myocyte loss and reactive cellular hypertrophy.

    Authors: , , , - Circulation Research 1991 cited by 771

  4. Apoptosis in the Failing Human Heart

    Authors: , , , , , , , , , , , - New England Journal of Medicine 1997 cited by 1,683

  5. Gender differences and aging: Effects on the human heart

    Authors: , , , , , , - Journal of the American College of Cardiology 1995 cited by 569

  6. Oxidative Stress–Mediated Cardiac Cell Death Is a Major Determinant of Ventricular Dysfunction and Failure in Dog Dilated Cardiomyopathy

    Authors: , , , , , , , , - Circulation Research 2001 cited by 381

  7. Senescence and Death of Primitive Cells and Myocytes Lead to Premature Cardiac Aging and Heart Failure

    Authors: , , , , , , , , , , , - Circulation Research 2003 cited by 388

  8. Myocardial Cell Death in Human Diabetes

    Authors: , , , , , , , - Circulation Research 2000 cited by 798

  9. Local myocardial insulin-like growth factor 1 (IGF-1) delivery with biotinylated peptide nanofibers improves cell therapy for myocardial infarction

    Authors: , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2006 cited by 613

  10. Stretch-induced programmed myocyte cell death.

    Authors: , , , , , , , , - Journal of Clinical Investigation 1995 cited by 650

  11. Apoptotic and necrotic myocyte cell deaths are independent contributing variables of infarct size in rats.

    Authors: , , , , , , , , - 1996 cited by 1,044

  12. Cardiac Stem Cell and Myocyte Aging, Heart Failure, and Insulin-Like Growth Factor-1 Overexpression

    Authors: , , , , , , , , , , , , , , - Circulation Research 2004 cited by 540

  13. Ablation of telomerase and telomere loss leads to cardiac dilatation and heart failure associated with p53 upregulation

    Authors: , , , , , , , , , - The EMBO Journal 2002 cited by 309

  14. Exogenous High-Mobility Group Box 1 Protein Induces Myocardial Regeneration After Infarction via Enhanced Cardiac C-Kit + Cell Proliferation and Differentiation

    Authors: , , , , , , , , , , , , , , - Circulation Research 2005 cited by 286

  15. Ventricular Myocytes Are Not Terminally Differentiated in the Adult Mammalian Heart

    Authors: , - Circulation Research 1998 cited by 388

  16. Protein Aggregates and Novel Presenilin Gene Variants in Idiopathic Dilated Cardiomyopathy

    Authors: , , , , , , , , , , , , , , , - Circulation 2010 cited by 139

  17. Evidence That Human Cardiac Myocytes Divide after Myocardial Infarction

    Authors: , , , , , , , , , , - New England Journal of Medicine 2001 cited by 1,421

  18. Structural basis of end-stage failure in ischemic cardiomyopathy in humans.

    Authors: , , , , , , , , , - Circulation 1994 cited by 605

  19. Myocyte Death, Growth, and Regeneration in Cardiac Hypertrophy and Failure

    Authors: , , , - Circulation Research 2003 cited by 501

  20. Anthracycline Cardiomyopathy Is Mediated by Depletion of the Cardiac Stem Cell Pool and Is Rescued by Restoration of Progenitor Cell Function

    Authors: , , , , , , , , , , , , , , - Circulation 2009 cited by 268

  21. Cardiac Progenitor Cells and Biotinylated Insulin-Like Growth Factor-1 Nanofibers Improve Endogenous and Exogenous Myocardial Regeneration After Infarction

    Authors: , , , , , , , , , , , , - Circulation 2009 cited by 218

  22. Cardiac-specific overexpression of insulin-like growth factor 1 attenuates aging-associated cardiac diastolic contractile dysfunction and protein damage

    Authors: , , , , , , , - American Journal of Physiology-Heart and Circulatory Physiology 2006 cited by 102

  23. RETRACTED: Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomised phase 1 trial

    Authors: , , , , , , , , , , , , , , , , , , , - The Lancet 2011 cited by 1,281

  24. Administration of Cardiac Stem Cells in Patients With Ischemic Cardiomyopathy: The SCIPIO Trial

    Authors: , , , , , , , , , , , , - Circulation 2012 cited by 432